Mavens Biotech (Delisted) share price
BSE: 590083
MAVENS BIOTECH LTD. · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2008
Last traded ₹0.47 on 7 Mar 2017
Delisted on 6 Apr 2017.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Feb 2017
Jan 2017
18 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nov 2016
Oct 2016
22 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Results for the quarter to Dec 2016
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹0.21 Cr−8.9% on a year ago · −40.6% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- ₹0.01 Cr−82.4% on a year ago · 0.0% on the quarter before
- Net margin
- 4.4%
From revenue to net profit, ₹ crore
- Revenue0.2
- Depreciation0.0
- Profit before tax0.0
- Net profit0.0
Mavens Biotech results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2016. Results for the quarter to Mar 2017 were due by 30 May 2017, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹7.20 Cr, quarter to Mar 2014; lowest ₹0.18 Cr, quarter to Sep 2014A loss in 1 of the 11 quarters with results on record
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 11.3 | 11.4 | 11.6 | 11.2 | 11.6 | 11.2 | 10.4 | 9.3 | 7.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.2 | 0.2 | – | 0.2 | 0.3 | 0.2 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 10.9 | 11.0 | 11.2 | 10.7 | 11.3 | 10.9 | 10.1 | 9.1 | 7.3 | – | – | – | – | – | – | – | – | – | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – |
| Profit before tax | 0.2 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | −0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | – | 0.0 | 0.0 | 0.0 |
| Net profit | 0.2 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | −0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | – | 0.0 | 0.0 | 0.0 |
| Net margin | 1.7% | 1.6% | 1.5% | 2.7% | 0.8% | 0.9% | 1.3% | 0.8% | −3.3% | 17.3% | 17.2% | 17.8% | 3.3% | 18.5% | 11.8% | 22.7% | – | 4.7% | 2.6% | 4.4% |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary | ₹0.02 | ₹0.02 | ₹0.02 | ₹0.03 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 | −₹0.02 | ₹0.00 | – | ₹0.00 | ₹0.00 | – | – | – | – | – | – | – |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2016.
8 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
Peak revenue ₹56 Cr, year to Mar 2011; lowest ₹1.06 Cr, year to Mar 2015
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Mar 2015
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue1.1
- Depreciation−0.3
- Other income+0.1
- Profit before tax0.1
- Tax0.0
- Net profit0.1
Profit and loss
Standalone, ₹ crore, years to March.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 20.8 | 21.6 | 47.4 | 56.0 | 45.6 | 45.8 | 38.2 | 1.1 |
| – | – | 43.8 | – | – | – | – | – | |
| Materials and goods bought | – | 17.6 | 39.4 | – | 43.7 | 44.2 | 37.4 | – |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary | – | – | 3.6 | – | – | – | – | – |
| Operating margin | – | – | 7.7% | – | – | – | – | – |
| Depreciation and amortisation | 0.1 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 0.3 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | – | – | 3.3 | – | – | – | – | – |
| Other income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | – | – | 0.0 | – | – | – | – | – |
| Profit before tax | 0.8 | 1.0 | 3.4 | 0.9 | 0.8 | 0.7 | 0.1 | 0.1 |
| Tax | 0.3 | 0.4 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net profit | 0.5 | 0.6 | 3.3 | 0.9 | 0.7 | 0.7 | 0.1 | 0.1 |
| Net margin | 2.6% | 2.7% | 6.9% | 1.6% | 1.5% | 1.5% | 0.2% | 11.9% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2008, Mar 2009, Mar 2011, Mar 2012, Mar 2013, Mar 2014 and Mar 2015: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March.
| Ratio | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | 3.9% | 119.7% | 18.1% | −18.6% | 0.6% | −16.7% | −97.2% |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | 10.5% | 456.9% | −72.2% | −23.2% | 0.6% | −90.4% | 85.3% |
| Earnings per share growthEarnings per share growth. This year's earnings per share less last year's, on the same share count, divided by last year's, times 100; blank where last year's is not above nought. Earnings per share growth in the glossary | – | – | – | – | 0.0% | −83.3% | 10.0% |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | – | 545.5 | – | – | – | – | – |
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2015.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | −53.3% | −71.5% |
| Profit growth, yearly rateProfit growth, yearly rate. 3 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | −47.9% | −43.6% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | 3.4% | 4.5% |
Accounting checks
Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Effective tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossaryPublished threshold 17.16 per cent | 35.96 | 38.05 | 2.11 | −0.11 | 12.78 | 5.23 | 8.11 | 2.33 |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Mar 2015, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +24.5% | – | – | 0.0% |
| 3 years | −34.5% | −43.6% | +16.2% | 0.0% |
| 5 years | −58.3% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth and the change in P/E over 1 and 5 years are left empty: the earnings per share stated for one end does not match that year's profit and share count, and no share count is on record to work it out.
Mavens Biotech share price by year
Each calendar year to 2017.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2017 | 0.47 | −19.0% | 0.69 | 0.45 |
| 2016 | 0.58 | −1.7% | 0.81 | 0.44 |
| 2015 | 0.59 | −22.4% | 0.90 | 0.51 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2017 close is its last trade, on 7 Mar 2017.
Recent sessions
The 10 trading days to 7 Mar 2017, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 7 Mar 2017 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 800 |
| 6 Mar 2017 | 0.49 | 0.50 | 0.49 | 0.49 | 0.49 | 7,181 |
| 3 Mar 2017 | 0.53 | 0.53 | 0.51 | 0.51 | 0.51 | 8,989 |
| 2 Mar 2017 | 0.55 | 0.55 | 0.53 | 0.53 | 0.55 | 14,000 |
| 1 Mar 2017 | 0.57 | 0.57 | 0.55 | 0.55 | 0.56 | 7,250 |
| 28 Feb 2017 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 600 |
| 27 Feb 2017 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 100 |
| 23 Feb 2017 | 0.66 | 0.66 | 0.63 | 0.63 | 0.65 | 19,517 |
| 20 Feb 2017 | 0.69 | 0.69 | 0.66 | 0.66 | 0.69 | 4,509 |
| 17 Feb 2017 | 0.67 | 0.69 | 0.64 | 0.69 | 0.66 | 33,325 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 16 Apr 2015 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for. |
| 25 Aug 2008 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- BSE code
- 590083
- ISIN
- INE856C01047
- Website
- www.mavensbiotech.com
- CIN
- L17297WB1981PLC034226
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1981
- Registered office
- Clive Row, 4th Floor No-4, Room No.407, Kolkata 700001, West Bengal
- Share registrar
- Adroit Corporate Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments